Dexcom Beats Q4 Estimates and Hits $4.66 Billion in Annual Revenue as the Continuous Glucose Monitor Revolution Expands Far Beyond Traditional Diabetes Care
Dexcom reported Q4 revenue of $1.26 billion, a 13% year-over-year increase, as the diabetes technology leader guides for 11-13% growth in 2026 and the CGM market expands to new patient populations.